Gilead Sciences, Inc. (GIS.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 155.3B |
| Enterprise Value | 173.78B |
| P/E Ratio | -54.75 |
| PEG Ratio | 0.41 |
| Price/Sales Ratio | 6.79 |
| Price/Book Ratio | 16.17 |
| Enterprise/Revenue | 7.43 |
| Enterprise/EBITDA | 178.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.12 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.22 |
Income Statement
| Revenue | 29.45B |
| Revenue/Share | 24.95 |
| Gross Profit | 25.52B |
| EBITDA | 13.58B |
| Net Income | 8.51B |
| Diluted EPS | 6.78 |
Balance Sheet
| Total Cash | 7.84B |
| Total Cash/Share | 5.18 |
| Total Debt | 25.86B |
| Total Debt/Equity | 2.01 |
| Current Ratio | 1.38 |
| Book Value Per Share | 10.43 |
Price History
| 52-Week Change | 46.87 |
| 52-Week High | 157.02 |
| 52-Week Low | 99.98 |
| Moving Average 50 Days | 135.9 |
| Moving Average 200 Days | 122.44 |
Statistics
| Average Volume | 1,008 |
| Shares Outstanding | 1.24B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.25 |
| Trailing Annual Dividend Yield | 1.91 |
| Payout Ratio | -1.06 |
| Last Split Factor | 2:1 |
| Last Split Date | January 28, 2013 |
AD
